---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-032697"
form_type: "8-K"
ticker: "TELA"
cik: "0001561921"
company_name: "TELA Bio, Inc."
filed_at: "2026-03-20T23:59:59+00:00"
generated_at: "2026-05-15T09:29:12.543873+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# TELA Bio receives Nasdaq deficiency notice for bid price below $1.00

## Summary
- Nasdaq notified TELA on March 17, 2026 that bid price closed below $1.00 for 30 consecutive business days.
- Company has until September 14, 2026 to regain compliance by closing at $1.00 for 10 consecutive days.
- Stock continues trading on Nasdaq Global Market under symbol TELA; no immediate delisting effect.
- If not cured by September 14, TELA may transfer to Nasdaq Capital Market for a second 180-day cure period.
- Company says it will monitor bid price and consider options to regain compliance; no assurance of success.

## SEC filing metadata
- accession: 0001104659-26-032697
- form_type: 8-K
- ticker: TELA
- cik: 0001561921
- company_name: TELA Bio, Inc.
- filed_at: 2026-03-20T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1561921/000110465926032697/0001104659-26-032697-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1561921/000110465926032697/tm269374d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-032697
- JSON: https://secwatch.observer/filing/0001104659-26-032697.json
- Plain text: https://secwatch.observer/filing/0001104659-26-032697.txt

## Source-grounded claims
- claim_id: af1336fbfe51e432906b3226138ab95d9fd5c2fd
  claim: TELA Bio, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).
  evidence_excerpt: March 17, 2026, TELA Bio, Inc. (the “ Company ”) received a deficiency letter from the Nasdaq Listing Qualifications Department (the “ Staff ”) of the Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company’s common stock has been below the minimum $1.00 per share required for continued listing on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(a)(1) (“ Rule 5450(a)(1) ”). The Nasdaq deficiency letter has no immediate effect on the listing of the Company’s common stock, and its common stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1561921/000110465926032697/0001104659-26-032697-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.